Shanghai Pharmaceuticals, one of China’s biggest drug manufacturers and distributors, is to raise up to $2.2bn through an offering of new shares in Hong Kong, according to people close to the transaction.
知情人士称，manbetx3.0 最大制药商和药物分销商之一上海医药(Shanghai Pharmaceuticals)，将通过在香港发行新股筹资至多22亿美元。
您已阅读8%（276字），剩余92%（3150字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。